107 related articles for article (PubMed ID: 3117091)
1. Absence of functional activity of tissue plasminogen activator in patients with severe forms of von Willebrand's disease.
Jeanneau C; Ounhoughene Bachouchi N; Gorin I; Meimon G; Sultan Y
Br J Haematol; 1987 Sep; 67(1):79-88. PubMed ID: 3117091
[TBL] [Abstract][Full Text] [Related]
2. Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.
Wieczorek I; Ludlam CA; MacGregor IR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):329-34. PubMed ID: 8075304
[TBL] [Abstract][Full Text] [Related]
3. Impaired fibrinolytic response to DDAVP in patients with von Willebrand's disease.
Sultan Y; Loyer F; Venot A
Nouv Rev Fr Hematol (1978); 1992; 34(1):55-60. PubMed ID: 1523100
[TBL] [Abstract][Full Text] [Related]
4. Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.
Bykowska K; Letowska M; Sabliński J; Binder BR; Kopeć M; Lopaciuk S
Acta Haematol Pol; 1994; 25(3):261-8. PubMed ID: 7992599
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
[TBL] [Abstract][Full Text] [Related]
6. Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Ludlam CA; Peake IR; Allen N; Davies BL; Furlong RA; Bloom AL
Br J Haematol; 1980 Jul; 45(3):499-511. PubMed ID: 6775673
[TBL] [Abstract][Full Text] [Related]
7. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
[TBL] [Abstract][Full Text] [Related]
8. Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.
MacGregor IR; Roberts EM; Prowse CV; Broomhead AF; Ozolins M; Litka P
Thromb Haemost; 1988 Feb; 59(1):34-9. PubMed ID: 3129807
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic activity and species of plasminogen activator in human tears.
Hayashi K; Sueishi K
Exp Eye Res; 1988 Feb; 46(2):131-7. PubMed ID: 3127227
[TBL] [Abstract][Full Text] [Related]
10. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
11. Abnormal fibrinolysis in healthy male cigarette smokers: role of plasminogen activator inhibitors.
Haire WD; Goldsmith JC; Rasmussen J
Am J Hematol; 1989 May; 31(1):36-40. PubMed ID: 2495714
[TBL] [Abstract][Full Text] [Related]
12. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
Montgomery RR; Zimmerman TS
J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
[TBL] [Abstract][Full Text] [Related]
14. Endothelial stimulation by DDAVP in von Willebrand's disease and haemophilia.
Greer IA; McLaren M; Belch JJ; Lowe GD; Forbes CD
Haemostasis; 1986; 16(1):15-9. PubMed ID: 3084364
[TBL] [Abstract][Full Text] [Related]
15. Response of fibrinolytic proteins and endothelin 1 to venous occlusion in patients on chronic hemodialysis.
Tomura S; Ando R; Chida Y; Ida T; Hirata Y; Marumo F; Tsuchiya S
Nephron; 1997; 77(4):394-8. PubMed ID: 9434059
[TBL] [Abstract][Full Text] [Related]
16. Different tissue plasminogen activator release in the arm and leg during venous occlusion is equalized after DDAVP infusion.
Keber D; Stegnar M; Kluft C
Thromb Haemost; 1990 Feb; 63(1):72-5. PubMed ID: 2111049
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
Lian EC; Deykin D
Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
[TBL] [Abstract][Full Text] [Related]
18. Relationship between age and plasma t-PA, PA-inhibitor, and PA activity.
Hashimoto Y; Kobayashi A; Yamazaki N; Sugawara Y; Takada Y; Takada A
Thromb Res; 1987 Jun; 46(5):625-33. PubMed ID: 3114907
[TBL] [Abstract][Full Text] [Related]
19. Familial hypofibrinolysis and venous thrombosis.
Petäjä J; Rasi V; Myllylä G; Vahtera E; Hallman H
Br J Haematol; 1989 Mar; 71(3):393-8. PubMed ID: 2495018
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
